Skip to main content
Clinical Trials/JPRN-UMIN000010927
JPRN-UMIN000010927
Recruiting
未知

Biomarker discovery and development of therapy for aortic aneurysm - Biomarker discovery and development of therapy for aortic aneurysm

Yokohama City University Graduate School of Medicine0 sites150 target enrollmentJune 12, 2013
ConditionsAortic aneurysm

Overview

Phase
未知
Intervention
Not specified
Conditions
Aortic aneurysm
Sponsor
Yokohama City University Graduate School of Medicine
Enrollment
150
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 12, 2013
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Yokohama City University Graduate School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Discovery of Novel Biomarkers for the Diagnosis of TB DiseaseA15Respiratory tuberculosis, bacteriologically and histologically confirmed
DRKS00032445Roche360
Recruiting
Not Applicable
Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1)DM1Steinerts disease10029299
NL-OMON50021Radboud Universitair Medisch Centrum20
Recruiting
Not Applicable
Clinical, molecular and functional biomarkers for PROgnosis, pathomechanisms and treatment strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)Coronavirus Disease 19 (COVID-19)U07.1J12J13J14J15J16J17J18COVID-19, virus identifiedViral pneumonia, not elsewhere classifiedPneumonia due to Streptococcus pneumoniaePneumonia due to Haemophilus influenzaeBacterial pneumonia, not elsewhere classifiedPneumonia due to other infectious organisms, not elsewhere classifiedPneumonia in diseases classified elsewherePneumonia, organism unspecified
DRKS00022871CAPNETZ STIFTUNG, Geschäftsstelle an der Medizinischen Hochschule Hannover400
Completed
Not Applicable
Clinical, molecular and functional biomarkers for PROgnosis, pathomechanisms and treatment strategies of COVID-19 (PROVID) - (PROVID-PROGRESS)U07.1J12J13J14J15J16J17J18COVID-19, virus identifiedViral pneumonia, not elsewhere classifiedPneumonia due to Streptococcus pneumoniaePneumonia due to Haemophilus influenzaeBacterial pneumonia, not elsewhere classifiedPneumonia due to other infectious organisms, not elsewhere classifiedPneumonia in diseases classified elsewherePneumonia, organism unspecified
DRKS00023277Charité – Universitätsmedizin Berlin, Med. Klinik m. S. Infektiologie und Pneumologie, und Arbeitsbereich Pulmonale Inflammation94
Completed
Not Applicable
The psychological health benefits of mindfulness-based stress reduction in family caregivers of patients with dementiaSelf-perceived stress, depression, burden and grief in non-professional caregivers of dementia patientsMental and Behavioural Disorders
ISRCTN53169488Icahn School of Medicine at Mount Sinai (USA)20